Hearing Loss, Ototoxic: Clinical Trials

1 trial for Hearing Loss, Ototoxic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Hearing Loss, Ototoxic: new trials by email Literature Review of Hearing Loss, Ototoxic trials Research Report on Hearing Loss, Ototoxic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
Dexamethasone, Hyaluronic acid - Hearing Loss, Sudden, Hearing Loss, Ototoxic
Phase 1 / Phase 2CompletedSeoul National University Hospital152021-07-222024-10-24

Narrower conditions

Hearing Loss (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Hearing Loss, Sudden (1)  ·  Meniere Disease (1)

Broader conditions

Ear Diseases (1)  ·  Endolymphatic Hydrops (1)  ·  Hearing Disorders (1)  ·  Hearing Loss, Sensorineural (1)  ·  Labyrinth Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Dexamethasone (1)  ·  Hyaluronic Acid (1)

Sponsors

Seoul National University Hospital (1)

Countries

South Korea (1)